Clinical Trials

Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene autoleucel (cilta-cel) Out-of-Specification (OOS) in patients with Multiple Myeloma

Cancer Answer Line 866.223.8100

Details

IRB Study Number 22-1024

Status Recruiting

Institute Taussig Cancer Institute

Description

none

Inclusion Criteria

none

Exclusion Criteria

none

Cancer Answer Line 866.223.8100